Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests that empower consumers to prevent certain chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs.
VN:F [1.9.7_1111]
Rating: 1.0/5 (1 vote cast)
VN:F [1.9.7_1111]
Interleukin Genetics Inc., 1.0 out of 5 based on 1 rating